Carbetapentane

Carbetapentane

SCHEMBL160096

CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1.O=C(O)CC(O)(CC(=O)O)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SIGMAR1

The experimentally established mechanism targets of Carbetapentane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 known ✓ Q99720 2/20 0.80
ALDH1A1 P00352 5/20 1.00
KDM4E B2RXH2 3/20 1.00
LMNA P02545 3/20 1.00
CYP1A2 P05177 3/20 1.00
CYP3A4 P08684 3/20 1.00
CYP2D6 P10635 3/20 1.00
TSHR P16473 3/20 1.00
TDP1 Q9NUW8 2/20 1.00
NFKB1 P19838 1/20 1.00
PMP22 Q01453 1/20 1.00
HIF1A Q16665 1/20 1.00
CHRM2 P08172 6/20 0.80
CHRM1 P11229 5/20 0.80
PRCP P42785 2/20 0.80
SLC22A1 O15245 1/20 0.80
THRB P10828 1/20 0.80
HTT P42858 1/20 0.80
TMEM97 Q5BJF2 1/20 0.80
POLB P06746 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxeladin SCHEMBL1354034 0.92 ALDH1A1 (0.85) ALDH1A1KDM4ELMNACYP1A2CYP3A4
Carbetapentane SCHEMBL67879 0.90 CHRM2 (1.00) ALDH1A1KDM4ELMNACYP1A2CYP3A4
Carbetapentane SCHEMBL15516338 0.90 CHRM2 (1.00) ALDH1A1KDM4ELMNACYP1A2CYP3A4
Carbetapentane SCHEMBL5174918 0.89 CHRM2 (0.98) ALDH1A1KDM4ELMNACYP1A2CYP3A4
Carbetapentane SCHEMBL15512243 0.88 CHRM2 (0.95) ALDH1A1KDM4ELMNACYP1A2CYP3A4
Caramiphen SCHEMBL181285 0.83 PRCP (1.00) ALDH1A1KDM4ELMNACYP1A2CYP3A4
Carbetapentane SCHEMBL7614465 0.82 CHRM2 (0.84) ALDH1A1KDM4ELMNACYP1A2CYP3A4
Caramiphen SCHEMBL1374820 0.82 ALDH1A1 (1.00) ALDH1A1KDM4ELMNACYP1A2CYP3A4
Caramiphen SCHEMBL10898559 0.82 PRCP (0.97) ALDH1A1KDM4ELMNACYP1A2CYP3A4
Hydrochloric Acid SCHEMBL7383119 0.81 ALDH1A1 (0.97) ALDH1A1KDM4ELMNACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2585 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025009819-A1 CUTTABLE AND CONSUMABLE TAPE-TYPE OR BAR-TYPE PREPARATION ENABLING DRUG DOSE CONTROL THROUGH LENGTH 충북대학교 산학협력단 2025-01-09 WO claimed
EP-4298186-A1 THERMAL CATALYTIC PYROLYSIS PLANT FOR THE PRODUCTION OF DIESEL, PETROL, FUEL OIL AND GAS, OBTAINED FROM RECYCLED PLASTICS BY A STEADY STATE PROCESS CARRIED OUT AT HIGH PRESSURE AND WITH FIXED BED CATALYSTS Fioravante, Giuseppe (IT) 2024-01-03 EP claimed
US-20230285405-A1 Pharmaceuticals for Treating or Preventing Nidoviruses and Picornaviruses THE UNIVERSITY OF CHICAGO (US) 2023-09-14 US claimed
CN-115813886-A Pentoxyverine citrate oral film agent and preparation method thereof 中国药科大学 2023-03-21 CN claimed
CN-115504498-A Preparation method of nano calcium carbonate for drug carrier 中国人民解放军军事科学院防化研究院 2022-12-23 CN claimed
CN-113278598-B Biological enzyme system for preparing drug metabolites and application thereof 山东大学 2022-08-30 CN claimed
CN-111208231-B Method for simultaneously detecting six illegally added compounds in plant beverage 广东省药品检验所(广东省药品质量研究所、广东省口岸药品检验所) 2022-07-22 CN claimed
CN-113788757-B Pentoxyverine citrate hapten, antigen, antibody, detection device and preparation method 广东江门中医药职业学院 2022-02-18 CN claimed
WO-2022032113-A1 PHARMACEUTICALS FOR TREATING OR PREVENTING NIDOVIRUSES AND PICORNAVIRUSES THE UNIVERSITY OF CHICAGO (US) 2022-02-10 WO claimed
CN-113788757-A Pentoxyverine citrate hapten, antigen, antibody, detection device and preparation method 广东江门中医药职业学院 2021-12-14 CN claimed
EP-0219458-B1 MEDICAMENT ADSORBATES AND THEIR PREPARATION WARNER-LAMBERT COMPANY (US) 1990-05-23 EP claimed
EP-0351897-A2 Skin penetration system for salts of amine-functional drugs THE PROCTER & GAMBLE COMPANY (US) 1990-01-24 EP claimed
US-4882153-A Confectionery delivery system for antitussives WARNER LAMBERT CO. (US) 1989-11-21 US claimed
EP-0132472-B1 MEDICATED PRODUCTS CONTAINING A MAGNESIUM TRISILICATE ADSORBENT WITH A MEDICAMENT DRUG ADSORBED THEREON WARNER-LAMBERT COMPANY (US) 1989-06-21 EP claimed
US-4753800-A DRUGS ADSORBED ONTO MAGNESIUM ALUMINUM STEARATE WARNER-LAMBERT COMPANY (US) 1988-06-28 US claimed
EP-0241615-A1 A pharmaceutical composition of phenindamine having enhanced release characteristics WARNER-LAMBERT COMPANY (US) 1987-10-21 EP claimed
EP-0219458-A2 Medicament adsorbates and their preparation WARNER-LAMBERT COMPANY (US) 1987-04-22 EP claimed
US-4650663-A FLAKES, INTERSTITIAL SPACES WARNER-LAMBERT COMPANY (US) 1987-03-17 US claimed
EP-0189861-A2 Percutaneous absorption accelerator for ionic water-soluble medicine SHOWA DENKO KABUSHIKI KAISHA (JP) 1986-08-06 EP claimed
EP-0132472-A1 Medicated products containing a magnesium trisilicate adsorbent with a medicament drug adsorbed thereon WARNER-LAMBERT COMPANY (US) 1985-02-13 EP claimed